Jason Jones, MD
Ophthalmology · Sioux City, IANPI 1922002872
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $75,145 of the $83,385 with a category attached, or 90.1%. Johnson & Johnson Surgical Vision, Inc. accounts for 76.3% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2022 at $30,699 and has fallen 97.9% since, to $645 in 2025. Among ophthalmology clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 153 payments — averaging $545.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Surgical Vision, Inc.$64K
- Ivantis, Inc$11K
- Carl Zeiss Meditec USA, Inc.$6K
- AbbVie$449
- Rxsight Inc$442
- Alcon$412
- plus $2K from 15 others
Across 261 payments — averaging $6944.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Johnson & Johnson Surgical Vision, Inc.$1.4M
- Glaukos Corporation$329K
- Alcon Research LLC$60K
- Ivantis, Inc$9K
What the payments were for
- Consulting fees$75,14590%
- Travel & lodging$2,1233%
- Food & beverage$5,9187%
- Education$800%
- Gifts$1190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | 56 | $63,631 |
| Ivantis, Inc | 14 | $10,861 |
| Carl Zeiss Meditec USA, Inc. | 12 | $5,835 |
| AbbVie(2 entities) | 16 | $449 |
| Rxsight Inc | 4 | $442 |
| Alcon | 9 | $412 |
| The Cameron-ehlen Group, Inc. | 3 | $294 |
| Amgen(2 entities) | 13 | $238 |
| Biotissue Holdings Inc. | 6 | $234 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 7 | $218 |
| Lensar, Inc. | 2 | $201 |
| Glaukos Corporation | 2 | $186 |
| Beaver-visitec International, Inc. | 1 | $109 |
| Apellis Pharmaceuticals, Inc. | 1 | $92 |
| Carl Zeiss Meditec, Inc. | 1 | $65 |
| Astellas Pharma US Inc | 1 | $24 |
| Stemline Therapeutics Inc. | 1 | $23 |
| Genentech USA, Inc. | 1 | $22 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Sight Sciences, Inc. | 1 | $16 |
| Dompe US, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tecnis IOL$50,767
- Compact Intuitiv$32,589
- Healon Duet Pro$32,589
- CATALYS SYSTEM$11,652
- Hydrus$10,064
- CIRRUS HD-OCT$4,900
- Humphrey HFA$4,900
- IOLMaster 700$4,900
- VERACITY SURGICAL$4,900
- VisuMax$4,900
- AMO PHACO NEEDLE$1,327
- VERITAS Vision System$889
- Hydrus Microstent$761
- RXSIGHT INJECTOR HANDPIECE$442
- RXSIGHT CONTACT LENS$442
- RXSIGHT INJECTOR CARTRIDGE$442
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$442
- ARTEVO 800$346
- LIGHT ADJUSTABLE LENS (LAL)$234
- RXSIGHT LIGHT ADJUSTABLE LENS (RXLAL)$209
How this compares
$83,385 in reported general payments places this provider in the 95th percentile of 172 ophthalmology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ofloxacin | 841 | $8,203 |
| ProlensaBromfenac Sodium | 23 | $7,954 |
| Prednisolone Acetate | 146 | $5,516 |
| Ketorolac Tromethamine | 12 | $305 |
| Timolol Maleate | 21 | $113 |
| Latanoprost | 23 | $105 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bausch & Lomb, A Division Of Bausch Health US, LLCProlensa | $218 | $7,95423 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 172 ophthalmology providers in Iowa.
Other ophthalmology in Sioux City
- Michael WadzinskiSioux City$4K
- Edward HuHiawatha$160K
- Michael AbramoffIowa City$158K
- Stephen RussellIowa City$137K
- Jared NielsenWest Des Moines$117K
- Matthew RauenWest Des Moines$108K
- Christy BensonDes Moines$70K
- Alina DumitrescuIowa City$57K
- Keith CarterIowa City$54K
- Erin ShriverIowa City$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.